Characterization of the effect of naltrexone/bupropion on body composition

Documenti analoghi

• Total and H‐specific growth/differentiation factor 15 levels are unaffected by liraglutide or naltrexone/bupropion administration
  di: Sofia K. Konstantinidou, et al.
  Pubblicazione: (2024)
• Assessing the effects of naltrexone‐bupropion on hepatic steatosis and fibrosis in patients with T2DM and overweight or obesity: Insights from a placebo‐controlled trial
  di: Alina N. Saidi, et al.
  Pubblicazione: (2025)
• A cost‐effectiveness analysis of behavioural, pharmacological, and surgical obesity treatments in Canada
  di: Nisha Gupta, et al.
  Pubblicazione: (2025)
• Semaglutide withdrawal in adults with type 1 diabetes on pump therapy: A post‐hoc analysis from a double‐blinded randomized controlled trial
  di: Melissa‐Rosina Pasqua, et al.
  Pubblicazione: (2025)
• Changes to insulin requirements over time with semaglutide in adults with type 1 diabetes on insulin pump therapy: A post‐hoc analysis of a double‐blinded, randomised, crossover trial
  di: Melissa‐Rosina Pasqua, et al.
  Pubblicazione: (2025)